BioMed Realty Announces 2023 ESG Achievements

BioMed Realty is a portfolio company within Blackstone’s Core+ Life Sciences Real Estate strategy, which achieved a 5 Star Rating in the 2023 GRESB Real Estate Assessment.

More News

Press Release

BioMed Realty and CordenPharma Colorado Team Up for Expansion of Peptide Development Lab in New LEED® Gold-Certified Facility at Flatiron Park in Boulder

Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development

Press Release

BioMed Realty’s Gateway of Pacific Earns BOMA TOBY Award for Excellence in Life Science Operations

Gateway of Pacific was recognized for its best-in-class operations and its ability to support the specialized needs of life science and technology tenants through high-quality facilities management, reliable infrastructure, and a strong tenant experience.

Press Release

BioMed Realty and Babraham Research Campus Ltd Complete Lease-Up of Newest Building at Babraham Research Campus, with TRIMTECH Therapeutics and Tagomics

The leases reinforce the role of Babraham Research Campus as a focal point for early-stage and scaling life science companies seeking immediate access to high-quality, fully fitted laboratory infrastructure within one of Europe’s most established research ecosystems.